MDM2 and Castleman disease: Researchers have even reported immunohistochemical expression of MDM2 and CDK4 in Castleman disease.[18] Therefore, challenging cases warrant a comprehensive approach integrating clinical data, pathological morphology, immunophenotype, and molecular genetic findings.